JP6661613B2 - 心筋ブリッジ及び患者に及ぼす影響を自動的に判定するためのシステム及び方法 - Google Patents
心筋ブリッジ及び患者に及ぼす影響を自動的に判定するためのシステム及び方法 Download PDFInfo
- Publication number
- JP6661613B2 JP6661613B2 JP2017511180A JP2017511180A JP6661613B2 JP 6661613 B2 JP6661613 B2 JP 6661613B2 JP 2017511180 A JP2017511180 A JP 2017511180A JP 2017511180 A JP2017511180 A JP 2017511180A JP 6661613 B2 JP6661613 B2 JP 6661613B2
- Authority
- JP
- Japan
- Prior art keywords
- patient
- myocardial
- myocardial bridge
- bridge
- modeled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002107 myocardial effect Effects 0.000 title claims description 249
- 238000000034 method Methods 0.000 title claims description 132
- 230000000694 effects Effects 0.000 title description 7
- 210000004351 coronary vessel Anatomy 0.000 claims description 91
- 210000004165 myocardium Anatomy 0.000 claims description 45
- 230000017531 blood circulation Effects 0.000 claims description 30
- 230000006835 compression Effects 0.000 claims description 30
- 238000007906 compression Methods 0.000 claims description 30
- 210000000709 aorta Anatomy 0.000 claims description 14
- 238000013500 data storage Methods 0.000 claims description 6
- 238000002372 labelling Methods 0.000 claims 3
- 230000000004 hemodynamic effect Effects 0.000 description 19
- 238000010801 machine learning Methods 0.000 description 17
- 230000004962 physiological condition Effects 0.000 description 11
- 238000011282 treatment Methods 0.000 description 10
- 230000036772 blood pressure Effects 0.000 description 9
- 230000000747 cardiac effect Effects 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- JRWZLRBJNMZMFE-UHFFFAOYSA-N Dobutamine Chemical compound C=1C=C(O)C(O)=CC=1CCNC(C)CCC1=CC=C(O)C=C1 JRWZLRBJNMZMFE-UHFFFAOYSA-N 0.000 description 7
- 210000003484 anatomy Anatomy 0.000 description 7
- 210000001367 artery Anatomy 0.000 description 7
- 229960001089 dobutamine Drugs 0.000 description 7
- 230000007423 decrease Effects 0.000 description 6
- 238000004088 simulation Methods 0.000 description 6
- 230000035488 systolic blood pressure Effects 0.000 description 6
- 238000012549 training Methods 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 238000004891 communication Methods 0.000 description 5
- 230000003205 diastolic effect Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 230000035882 stress Effects 0.000 description 5
- 208000031481 Pathologic Constriction Diseases 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000008602 contraction Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 230000036262 stenosis Effects 0.000 description 4
- 208000037804 stenosis Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 230000035487 diastolic blood pressure Effects 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 230000000297 inotrophic effect Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000002608 intravascular ultrasound Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000013146 percutaneous coronary intervention Methods 0.000 description 3
- 230000009894 physiological stress Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 238000002583 angiography Methods 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 238000002586 coronary angiography Methods 0.000 description 2
- 229940124975 inotropic drug Drugs 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 238000012014 optical coherence tomography Methods 0.000 description 2
- 238000011369 optimal treatment Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000011422 pharmacological therapy Methods 0.000 description 2
- 238000011458 pharmacological treatment Methods 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000005641 tunneling Effects 0.000 description 2
- 208000004476 Acute Coronary Syndrome Diseases 0.000 description 1
- 206010002388 Angina unstable Diseases 0.000 description 1
- 206010003175 Arterial spasm Diseases 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 241001272720 Medialuna californiensis Species 0.000 description 1
- 208000007718 Stable Angina Diseases 0.000 description 1
- 208000007814 Unstable Angina Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010968 computed tomography angiography Methods 0.000 description 1
- 238000013170 computed tomography imaging Methods 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002169 extracardiac Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000000544 hyperemic effect Effects 0.000 description 1
- 238000012482 interaction analysis Methods 0.000 description 1
- 201000004332 intermediate coronary syndrome Diseases 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000012706 support-vector machine Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
- A61B5/004—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
- A61B5/0044—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/503—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/504—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of blood vessels, e.g. by angiography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/507—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for determination of haemodynamic parameters, e.g. perfusion CT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
- A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
- A61B6/5217—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0263—Measuring blood flow using NMR
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Optics & Photonics (AREA)
- High Energy & Nuclear Physics (AREA)
- Physiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dentistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Primary Health Care (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462043841P | 2014-08-29 | 2014-08-29 | |
| US62/043,841 | 2014-08-29 | ||
| US14/535,755 | 2014-11-07 | ||
| US14/535,755 US9390224B2 (en) | 2014-08-29 | 2014-11-07 | Systems and methods for automatically determining myocardial bridging and patient impact |
| PCT/US2015/045910 WO2016032825A1 (en) | 2014-08-29 | 2015-08-19 | Systems and methods for automatically determining myocardial bridging and patient impact |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019232521A Division JP7035004B2 (ja) | 2014-08-29 | 2019-12-24 | 心筋ブリッジ及び患者に及ぼす影響を自動的に判定するためのシステム及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017529146A JP2017529146A (ja) | 2017-10-05 |
| JP2017529146A5 JP2017529146A5 (enExample) | 2018-07-19 |
| JP6661613B2 true JP6661613B2 (ja) | 2020-03-11 |
Family
ID=54056271
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017511180A Active JP6661613B2 (ja) | 2014-08-29 | 2015-08-19 | 心筋ブリッジ及び患者に及ぼす影響を自動的に判定するためのシステム及び方法 |
| JP2019232521A Active JP7035004B2 (ja) | 2014-08-29 | 2019-12-24 | 心筋ブリッジ及び患者に及ぼす影響を自動的に判定するためのシステム及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019232521A Active JP7035004B2 (ja) | 2014-08-29 | 2019-12-24 | 心筋ブリッジ及び患者に及ぼす影響を自動的に判定するためのシステム及び方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US9390224B2 (enExample) |
| EP (1) | EP3185763B1 (enExample) |
| JP (2) | JP6661613B2 (enExample) |
| WO (1) | WO2016032825A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014182505A1 (en) | 2013-05-10 | 2014-11-13 | Stenomics, Inc. | Modeling and simulation system for optimizing prosthetic heart valve treatment |
| US9092743B2 (en) | 2013-10-23 | 2015-07-28 | Stenomics, Inc. | Machine learning system for assessing heart valves and surrounding cardiovascular tracts |
| US8958623B1 (en) | 2014-04-29 | 2015-02-17 | Heartflow, Inc. | Systems and methods for correction of artificial deformation in anatomic modeling |
| JP6300244B2 (ja) * | 2014-07-03 | 2018-03-28 | 富士通株式会社 | 生体シミュレーション装置、生体シミュレーション装置の制御方法、および生体シミュレーション装置の制御プログラム |
| US11071501B2 (en) | 2015-08-14 | 2021-07-27 | Elucid Bioiwaging Inc. | Quantitative imaging for determining time to adverse event (TTE) |
| US11094058B2 (en) | 2015-08-14 | 2021-08-17 | Elucid Bioimaging Inc. | Systems and method for computer-aided phenotyping (CAP) using radiologic images |
| US12008751B2 (en) | 2015-08-14 | 2024-06-11 | Elucid Bioimaging Inc. | Quantitative imaging for detecting histopathologically defined plaque fissure non-invasively |
| US11087459B2 (en) | 2015-08-14 | 2021-08-10 | Elucid Bioimaging Inc. | Quantitative imaging for fractional flow reserve (FFR) |
| US10176408B2 (en) | 2015-08-14 | 2019-01-08 | Elucid Bioimaging Inc. | Systems and methods for analyzing pathologies utilizing quantitative imaging |
| US11113812B2 (en) | 2015-08-14 | 2021-09-07 | Elucid Bioimaging Inc. | Quantitative imaging for detecting vulnerable plaque |
| US12026868B2 (en) | 2015-08-14 | 2024-07-02 | Elucid Bioimaging Inc. | Quantitative imaging for detecting histopathologically defined plaque erosion non-invasively |
| US11676359B2 (en) | 2015-08-14 | 2023-06-13 | Elucid Bioimaging Inc. | Non-invasive quantitative imaging biomarkers of atherosclerotic plaque biology |
| US11191490B2 (en) * | 2015-12-02 | 2021-12-07 | Siemens Healthcare Gmbh | Personalized assessment of patients with acute coronary syndrome |
| JP6570460B2 (ja) * | 2016-02-25 | 2019-09-04 | 富士フイルム株式会社 | 評価装置、方法およびプログラム |
| WO2018139973A1 (en) * | 2017-01-24 | 2018-08-02 | Tan Tock Seng Hospital | Apparatus, system and method for obtaining hemodynamic data of an individual |
| KR102744520B1 (ko) | 2017-10-06 | 2024-12-20 | 에모리 유니버시티 | 하나 이상의 동맥 세그먼트에 대한 혈역학 정보를 결정하기 위한 방법 및 시스템 |
| US11871995B2 (en) | 2017-12-18 | 2024-01-16 | Hemolens Diagnostics Sp. Z O.O. | Patient-specific modeling of hemodynamic parameters in coronary arteries |
| GB201820044D0 (en) * | 2018-10-29 | 2019-01-23 | Univ Oxford Innovation Ltd | Radiomic signature of an epicardial region |
| EP3899864B1 (en) | 2019-08-05 | 2025-11-05 | Elucid Bioimaging Inc. | Combined assessment of morphological and perivascular disease markers |
| US11532084B2 (en) * | 2020-05-11 | 2022-12-20 | EchoNous, Inc. | Gating machine learning predictions on medical ultrasound images via risk and uncertainty quantification |
| CN113139959B (zh) * | 2021-05-17 | 2021-10-01 | 北京安德医智科技有限公司 | 获得心肌桥图像的方法及装置、电子设备和存储介质 |
| CN113648059B (zh) * | 2021-08-26 | 2023-09-29 | 上海联影医疗科技股份有限公司 | 手术规划评估方法、计算机设备和存储介质 |
| CN113889238B (zh) * | 2021-10-25 | 2022-07-12 | 推想医疗科技股份有限公司 | 一种图像识别方法、装置、电子设备及存储介质 |
| KR102695790B1 (ko) * | 2022-03-03 | 2024-08-20 | 연세대학교 산학협력단 | 하이브리드 방식을 통한 관상동맥 ct 이미지에서의 관상동맥 및 상행 대동맥 자동 추출 시스템 및 그 방법 |
| CN114862787B (zh) * | 2022-04-29 | 2025-04-04 | 深圳睿心智能医疗科技有限公司 | 心肌图像检测装置、系统及存储介质 |
| CN115035064B (zh) * | 2022-06-10 | 2024-12-03 | 推想医疗科技股份有限公司 | 心肌桥深度确定系统、装置及存储介质 |
| EP4607534A1 (de) * | 2024-02-20 | 2025-08-27 | New World Anatomy UG | Computergestütztes verfahren zur steuerung biophysikalischer vorgänge anatomischer strukturen mit rückkopplungsmechanismus |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6106466A (en) * | 1997-04-24 | 2000-08-22 | University Of Washington | Automated delineation of heart contours from images using reconstruction-based modeling |
| WO2005055496A2 (en) | 2003-11-26 | 2005-06-16 | Viatronix Incorporated | System and method for optimization of vessel centerlines |
| WO2010046797A1 (en) * | 2008-10-23 | 2010-04-29 | Koninklijke Philips Electronics N.V. | Method for characterizing object movement from ct imaging data |
| JP2010115317A (ja) * | 2008-11-12 | 2010-05-27 | Toshiba Corp | 画像処理装置 |
| US8315812B2 (en) | 2010-08-12 | 2012-11-20 | Heartflow, Inc. | Method and system for patient-specific modeling of blood flow |
| US10311978B2 (en) | 2012-01-30 | 2019-06-04 | Siemens Healthcare Gmbh | Method and system for patient specific planning of cardiac therapies on preoperative clinical data and medical images |
| US10373700B2 (en) * | 2012-03-13 | 2019-08-06 | Siemens Healthcare Gmbh | Non-invasive functional assessment of coronary artery stenosis including simulation of hyperemia by changing resting microvascular resistance |
| KR101939778B1 (ko) | 2012-07-27 | 2019-01-18 | 삼성전자주식회사 | 필요 혈류량 결정 방법 및 장치, 혈류 영상 생성 방법 및 장치, 심근 관류 영상 처리 방법 및 장치 |
| US10433740B2 (en) * | 2012-09-12 | 2019-10-08 | Heartflow, Inc. | Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology |
| US9700219B2 (en) | 2013-10-17 | 2017-07-11 | Siemens Healthcare Gmbh | Method and system for machine learning based assessment of fractional flow reserve |
-
2014
- 2014-11-07 US US14/535,755 patent/US9390224B2/en active Active
-
2015
- 2015-08-19 EP EP15757607.5A patent/EP3185763B1/en active Active
- 2015-08-19 WO PCT/US2015/045910 patent/WO2016032825A1/en not_active Ceased
- 2015-08-19 JP JP2017511180A patent/JP6661613B2/ja active Active
-
2016
- 2016-06-14 US US15/181,949 patent/US10395776B2/en active Active
- 2016-06-14 US US15/181,894 patent/US10169542B2/en active Active
-
2019
- 2019-12-24 JP JP2019232521A patent/JP7035004B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10169542B2 (en) | 2019-01-01 |
| WO2016032825A1 (en) | 2016-03-03 |
| US9390224B2 (en) | 2016-07-12 |
| EP3185763A1 (en) | 2017-07-05 |
| JP2020044409A (ja) | 2020-03-26 |
| US20160063175A1 (en) | 2016-03-03 |
| US20160292384A1 (en) | 2016-10-06 |
| EP3185763B1 (en) | 2023-05-31 |
| US10395776B2 (en) | 2019-08-27 |
| JP2017529146A (ja) | 2017-10-05 |
| JP7035004B2 (ja) | 2022-03-14 |
| US20160292383A1 (en) | 2016-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6661613B2 (ja) | 心筋ブリッジ及び患者に及ぼす影響を自動的に判定するためのシステム及び方法 | |
| US20230148977A1 (en) | Systems and methods for numerically evaluating vasculature | |
| JP6522175B2 (ja) | 血管形状及び生理学から血流特性を推定するシステム及びその作動方法 | |
| EP3912550B1 (en) | System, method and computer program product for estimating perfusion | |
| US9043190B2 (en) | Systems and methods for identifying personalized vascular implants from patient-specific anatomic data | |
| JP6203410B2 (ja) | 患者固有の解剖学的構造の画像データから冠動脈プラークの脆弱性を予測するシステム及びシステムの作動方法 | |
| CN105078440B (zh) | 无创计算冠状动脉狭窄的血液动力学指标的方法和系统 | |
| CA2903146A1 (en) | Method and system for sensitivity analysis in modeling blood flow characteristics | |
| AU2020204940B2 (en) | Virtual stress test based on electronic patient data | |
| HK40050874B (zh) | 冠状动脉中的血液动力学参数的患者特定的建模 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180608 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180608 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20181116 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181218 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190312 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20190903 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191224 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20200106 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200131 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200212 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6661613 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |